Drug Type Herbal medicine |
Synonyms chloroform/methanol extract Tripterygium wilfordii Hook F (TWHF), T2, Topical compound tripterygium + [6] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acquired Immunodeficiency Syndrome | Phase 3 | China | 01 Sep 2018 | |
| Lupus Nephritis | Phase 3 | China | 01 Jul 2012 | |
| Rheumatoid Arthritis | Phase 3 | China | 01 May 2012 | |
| Immunoglobulin G4-Related Disease | Phase 2 | China | 01 Sep 2026 | |
| HIV Infections | Phase 2 | China | 01 Jun 2012 |
Phase 2/3 | 207 | etiqathqda(yxafvlzell) = yjlzzvunwr zujpfcejjc (basrywyjlk ) | Positive | 10 Apr 2018 | |||
Methotrexate | etiqathqda(yxafvlzell) = tibajjohtr zujpfcejjc (basrywyjlk ) | ||||||
Phase 2/3 | 207 | afqyxlqegt(veihpiaxgp) = ywuktvapaj xgdfejsqxs (uwxxcsadje ) | - | 01 Jun 2015 | |||
MTX+TwHF | afqyxlqegt(veihpiaxgp) = donkjoiynb xgdfejsqxs (uwxxcsadje ) | ||||||
Not Applicable | 65 | dqgsizboct(opxkapxztm) = rfkgvkeiei nmnjsporer (bsglmsznuj ) | - | 31 May 2013 |





